Literature DB >> 6329253

The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.

N D Bax, M S Lennard, G T Tucker, H F Woods, N R Porter, R G Malia, F E Preston.   

Abstract

The effects of three beta-adrenoceptor antagonists (propranolol, metoprolol and atenolol) on the serum kinetics and pharmacodynamics of warfarin given in a single oral dose (15 mg) were studied in six normal subjects. At the same degree of beta-adrenoceptor blockade, as assessed by the decrease of exercise tachycardia, propranolol increased the area under the serum warfarin concentration time curve (AUC) by 16.3 +/- 14.2 s.d.% (P less than 0.01) and the maximum serum warfarin concentration by 23.0 +/- 14.3 s.d.% (P less than 0.001). Atenolol increased the maximum serum warfarin concentration by 12.5 +/- 12.3% s.d. (P less than 0.05) but was without effect on warfarin AUC. Metoprolol had no effect on warfarin kinetics. The extent of changes in the prothrombin time and the plasma clotting Factor VII activity caused by warfarin were not altered by any of the beta-adrenoceptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329253      PMCID: PMC1463441          DOI: 10.1111/j.1365-2125.1984.tb02389.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Kinetics of warfarin absorption in man.

Authors:  A Breckenridge; M Orme
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

3.  Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.

Authors:  C S Deacon; M S Lennard; N D Bax; H F Woods; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

4.  Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.

Authors:  M Gibaldi; J R Koup
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Lack of effect of atenolol on antipyrine clearance.

Authors:  G T Tucker; N D Bax; M S Lennard; K Crewe; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

6.  Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.

Authors:  N D Bax; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

7.  Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

Authors:  A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

8.  High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin.

Authors:  T D Bjornsson; T F Blaschke; P J Meffin
Journal:  J Pharm Sci       Date:  1977-01       Impact factor: 3.534

9.  Interaction between warfarin and propranolol.

Authors:  A K Scott; B K Park; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

  9 in total
  8 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Drug interactions and beta blockers.

Authors:  L Beeley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

Review 3.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 4.  Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Authors:  Y W Lam; A M Shepherd
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

5.  Interaction between warfarin and propranolol.

Authors:  A K Scott; B K Park; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

Review 6.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 7.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

8.  Evaluation of knowledge of Health care professionals on warfarin interactions with drug and herb medicinal in Central Saudi Arabia.

Authors:  Mohamed N Al-Arifi; Syed Wajid; Nawaf K Al-Manie; Faisal M Al-Saker; Salmeen D Babelgaith; Yousif A Asiri; Ibrahim Sales
Journal:  Pak J Med Sci       Date:  2016 Jan-Feb       Impact factor: 1.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.